Personalized Immune Cell Treatment NKCL Classic
On July 4, NKCL Bio Group Inc. (CEO Shin, Donghwa) and I Partners Group (CEO Jung, Yiho) announced that they had signed an MOU for innovative technology in the medical field. I Partners Group is a specialized company that supplies programs that combine in various areas; such as, medical device, healt...
Dong-hwa Shin, chairman of NKCL Bio Group Inc.(NKCL Bio Group), was honored with the Grand Prize in the NK cell therapy category of the ‘2022 Consumer Selected Quality Satisfaction Award’. Celebrating its 13th anniversary this year, the '2022 Consumer Quality Satisfaction Award' is an award ceremon...
On June 28, the 'JTC Group of Companies ' visited NKCL Bio Group. NKCL Biogroup has explained its technological competitiveness of NK cell therapy, which is spotlighted as a next-generation anticancer treatment, to the 'JTC Group of Companies', and shared the future vision regarding the growth of imm...
On the 20th, the Cambodian economic delegation, the Reachsey Association, visiting Korea at the moment, visited NKCL Bio Group Inc. and announced that they discussed ways to cooperate in the bio industry between the two countries. The Cambodian economic delegation to Korea, the Reachsey Association, ...
NKCL Bio Group Inc. (Chairman Dong-Hwa Shin, hereinafter referred to as NKCL) announced that it had acquired a ‘T-4’ grade, an excellent company certification at Technology Credit Bureau(TCB) by NICE evaluation information, a nationally accredited technology credit rating agency. The Tech Credit Bu...
On the 9th, NKCL Bio Group Inc.’s Chairman Dong-Hwa Shin has won the grand prize in the ‘2022 Korea’s Influential CEO- Innovative Management Bio Sector’ hosted by TV Chosun and Digital Chosun Ilbo. The '2022 Korea's Influential CEO' is awarded among the CEOs of companies and institutions during t...
NKCL Bio Group Inc. announced on the 3rd that it had obtained the 'T-5' grade, an excellent company certification from the 'SCI’ Tech Credit Bureau, a technology credit evaluation company. The Tech Credit Bureau comprehensively analyzes and evaluates a company's technological prowess, such as techno...
As of April 29, 2022, NKCL Bio Group Inc. has announced that it had acquired three new patents: a polymer nanoparticle based cancer vaccine composition, a dendritic cell therapeutics for cancer, and a composition for preventing and treating cancer. The patents obtained this time are related to 'compo...
NK Immune Water of NKCL Bio Group announced that it provides props for KBS2 sports romance drama 'The Speed Going To You 493km'. KBS 2TV's new Wednesday-Thursday drama, 'The Speed Going To You 493km' is a hot sports romance in which a refreshing twenty-five, sports-oriented Park Tae-yang (Park Joo-hy...
On April 28 (Thursday), Maeil Business TV's 'Magazine Today' introduced the 'NK Cell Therapy' of NKCL Bio Group Inc.(‘NKCL’, ‘NKCL Bio Group’). Magazine Today is a representative comprehensive magazine program that easily delivers various information in daily life, such as companies, idea product...
